← Leaderboards
Russell Scott Dulman
University Of Illinois At Chicago
$153,308
Attributed
$153,308
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $51.8K · FY2020–22$100K$75K$50K$25K$0
'20
'21
'22
Funding mix
By agency
NIH$153,308 · 1
By mechanism
F30$153,308 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Subhash C Pandey$28,170,363
- Donald Lavelle$5,608,438
- John Varga$15,528,672
- Alessandro Guidotti$9,589,408
- Andrei V Gudkov$19,460,065
Others in their field
Other Emerging Leaders on “Addiction”
- Eve Jelstrom · The Emmes Company, Llc$35,258,152
- Jeffrey Reich · Sparian Biosciences, Inc.$17,713,936
- Emmanuel Aja Oga · Research Triangle Institute$17,220,162
- Suparna Goswami · Univ Of North Carolina Chapel Hill$16,919,767
- Mark Brian Reed · San Diego State University$13,246,314
- Nikej Shah · Nirsum Laboratories, Inc.$12,506,430
Research focus
AddictionAcetylationAlcohol Abuse TherapyAlcohol ConsumptionAgonistAlcohol ExposureAlcoholsAlcohol Use DisorderAmygdaloid StructureAnimalsAlcohol EffectBaseBehaviorBehavioralBiochemicalBrainCannabinoid ReceptorCannabinoid Receptor AntagonistCannabinoidsCell NucleusChronicChronic Alcohol IngestionCnr1 GeneComplex
Grant awards (3)
PHARMACOLOGICAL ANTAGONISM AND GENETIC MANIPULATION OF CANNABINOID CB1 RECEPTORS IN THE AMYGDALA TO REDUCE PROTRACTED ETHANOL CONSUMPTION$51,752
F30 · FY2022 · AA · contact PI
PHARMACOLOGICAL ANTAGONISM AND GENETIC MANIPULATION OF CANNABINOID CB1 RECEPTORS IN THE AMYGDALA TO REDUCE PROTRACTED ETHANOL CONSUMPTION$51,036
F30 · FY2021 · AA · contact PI
PHARMACOLOGICAL ANTAGONISM AND GENETIC MANIPULATION OF CANNABINOID CB1 RECEPTORS IN THE AMYGDALA TO REDUCE PROTRACTED ETHANOL CONSUMPTION$50,520
F30 · FY2020 · AA · contact PI